Quantum Computing – Pioneering the Future of Innovation
🌟 Don’t Miss Our Exciting Keynote and Panel Discussion! 🌟
💡 Topic: Quantum Computing – Pioneering the Future of Innovation
🚀 Date: April 2nd, 2025
🕒 Time: 5:00 - 8:00 PM
📍 Location: CIC Cambridge, One Broadway
Venue: Venture Cafe, Level 5
Join us for an engaging discussion into how quantum computing is revolutionizing the pharmaceutical industry. Our keynote speaker, Nash Palaniswamy, will offer insights into the latest trends in quantum computing. This will be followed by an expert panel discussion with top professionals from both quantum computing and pharmaceuticals, moderated by Larissa Biafano.
Together, we’ll dive into how quantum computing is revolutionizing drug discovery, accelerating development, and unlocking new possibilities in medicine. This event is organized by Qubit Pharmaceuticals, and hosted by TINS. A big shout out for DLA Piper for making this event possible!
Keynote Speaker/Panelist: Dr. Nash Palaniswamy is the Chief Commercial Officer at Quantinuum Inc., where he drives global sales, marketing, and business operations. Previously, he served as Vice President and General Manager of Global AI, HPC, and Graphics Sales and Solutions at Intel, leading a team of over 500 professionals and spearheading revenue growth across the AI, HPC, and data center graphics sectors. With over 20 years of experience in accelerator architectures and high-performance computing, Dr. Palaniswamy has held senior leadership roles at Conformative Systems, MSU Devices, and Motorola. He holds three patents, has received a Top Intel Achievement Award, and was named one of HPCwire’s People to Watch in 2021. Dr. Palaniswamy earned his Ph.D. and M.S. in Electrical and Computer Engineering from the University of Cincinnati.
Event & Panel Moderator: Larissa Bifano is a leading intellectual property attorney at DLA Piper, specializing in patent strategy, prosecution, and litigation with a focus on AI systems and emerging technologies. She advises companies across industries, from clean technologies to semiconductor processing, helping them navigate the legal landscape of innovation. Larissa has served as Lawyer in Residence at Harvard Business School's Rock Center for Entrepreneurship and works closely with startups and global tech firms on patent strategy and interprets review proceedings.
Panelists:
Dr. Rohit Arora is the Innovation Lead at Novo Nordisk Bio Innovation Hub in Boston, where he drives initiatives focused on integrating advanced data science and machine learning into healthcare innovations. Prior to joining Novo Nordisk, Dr. Arora was a Senior Application Scientist and Group Lead at Iktos, specializing in AI-driven drug discovery. He has also held research positions at Harvard Medical School and Beth Israel Deaconess Medical Center, where his work focused on bioinformatics and integrative genomics. Dr. Arora holds a Ph.D. in Computational Biology and an M.S. in Molecular Nano and Bio Photonics from École Normale Supérieure de Cachan.
Andrea de Souza is a recognized leader in digital transformation and artificial intelligence (AI), currently Corporate Development Officer at Qubit Pharmaceuticals. With a background that blends neuroscience, technology, and business, and a focus on the emerging frontier where quantum science, technology, and AI are transforming drug discovery and development, she has been recognized by Forbes as one of the Top 100 AI Leaders in Drug Discovery and Advanced Healthcare. Through her portfolio career, Andrea has held pivotal roles at Novo Nordisk, Eli Lilly, NVIDIA and the Broad Institute, where she architected and implemented transformative AI and digital strategies that advanced drug discovery, development, and commercialization. She holds an MBA from MIT Sloan and is a passionate advocate for STEM education.
Christophe Jurczak’s career includes strategic roles in government, energy and defense, as well as contributions to quantum computing at pioneer Silicon Valley startup QC Ware. He is co-founder and managing partner of Quantonation, the first venture capital firm dedicated exclusively to quantum technologies, and the largest early-stage investor in the sector with 32 portfolio companies worldwide as of Sept. 2024 and $210m AUM. Christophe sits on the boards of several startups and scale-ups, including PASQAL, Qubit Pharmaceuticals, QphoX, WeLinQ and Nord Quantique, as well as not for profit Unitary Fund, playing a key role in shaping the future of quantum technology. Christophe obtained his PhD in quantum physics under the supervision of 2022 Physics Nobel Laureate Alain Aspect.
Dr. William D. Oliver is the Henry Ellis Warren Professor of Electrical Engineering and Computer Science, as well as a Professor of Physics at MIT. He is the director of the Center for Quantum Engineering and the Research Laboratory of Electronics, where he leads research on superconducting qubits and quantum computing technologies. Prior to his current role, Dr. Oliver was a Laboratory Fellow at MIT Lincoln Laboratory, where he contributed to the development of the Quantum Information and Integrated Nanosystems Group. He is a Fellow of the AAAS and APS and serves on the National Quantum Initiative Advisory Committee. Dr. Oliver earned his Ph.D. in Electrical Engineering from Stanford University.
We look forward to seeing you there!